Skip to main content Accessibility help
×
Home
Hostname: page-component-559fc8cf4f-xbbwl Total loading time: 0.252 Render date: 2021-03-06T16:13:52.081Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013

Published online by Cambridge University Press:  12 October 2015

Lauren Epstein
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, Georgia
Isaac See
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Jonathan R. Edwards
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Shelley S. Magill
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Nicola D. Thompson
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Corresponding
E-mail address:

Abstract

OBJECTIVES

To determine the impact of mucosal barrier injury laboratory-confirmed bloodstream infections (MBI-LCBIs) on central-line–associated bloodstream infection (CLABSI) rates during the first year of MBI-LCBI reporting to the National Healthcare Safety Network (NHSN)

DESIGN

Descriptive analysis of 2013 NHSN data

SETTING

Selected inpatient locations in acute care hospitals

METHODS

A descriptive analysis of MBI-LCBI cases was performed. CLABSI rates per 1,000 central-line days were calculated with and without the inclusion of MBI-LCBIs in the subset of locations reporting ≥1 MBI-LCBI, and in all locations (regardless of MBI-LCBI reporting) to determine rate differences overall and by location type.

RESULTS

From 418 locations in 252 acute care hospitals reporting ≥1 MBI-LCBIs, 3,162 CLABSIs were reported; 1,415 (44.7%) met the MBI-LCBI definition. Among these locations, removing MBI-LCBI from the CLABSI rate determination produced the greatest CLABSI rate decreases in oncology (49%) and ward locations (45%). Among all locations reporting CLABSI data, including those reporting no MBI-LCBIs, removing MBI-LCBI reduced rates by 8%. Here, the greatest decrease was in oncology locations (38% decrease); decreases in other locations ranged from 1.2% to 4.2%.

CONCLUSIONS

An understanding of the potential impact of removing MBI-LCBIs from CLABSI data is needed to accurately interpret CLABSI trends over time and to inform changes to state and federal reporting programs. Whereas the MBI-LCBI definition may have a large impact on CLABSI rates in locations where patients with certain clinical conditions are cared for, the impact of MBI-LCBIs on overall CLABSI rates across inpatient locations appears to be more modest.

Infect. Control Hosp. Epidemiol. 2015;37(1):2–7

Type
Original Articles
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below.

Footnotes

PREVIOUS PRESENTATION: The results of this analysis were presented in part at ID Week 2014 Philadelphia, Pennsylvania, October 9, 2014. Abstract #1284.

References

1. KM., P. Public Reporting of Infections and the CLABSI Mandate. Infection Control Today Web site. http://www.infectioncontroltoday.com/articles/2011/01/public-reporting-of-infections-and-the-clabsi-mandate.aspx. Published January 17, 2011. Accessed February 2, 2015.Google Scholar
2. Pehar, M, Ristaino, P, Budd, A, et al. Application of the National Healthcare Safety Network (NHSN) Central Line Associated Bloodstream Infection (CLA-BSI) Definition to Oncology Patients: Impact in the Trenches, 2010. Presented at the International Conference on Healthcare-Associated Infections, March 18–22, 2010. Abstract #660.Google Scholar
3. Fraser, TG, Gordon, SM. CLABSI rates in immunocompromised patients: a valuable patient centered outcome? Clin Infect Dis 2011;52:14461450.CrossRefGoogle ScholarPubMed
4. Steinberg, JP, Robichaux, C, Tejedor, SC, Reyes, MD, Jacob, JT. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition. Infect Control Hosp Epidemiol 2013;34:171175.CrossRefGoogle ScholarPubMed
5. Sexton, DJ, Chen, LF, Anderson, DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol 2010;31:12861289.CrossRefGoogle ScholarPubMed
6. Rettig, SL, Gross, KA, Ditaranto, S, et al. Central line-associated bloodstream infections (CLABSI) in oncology patients: the impact of mucositis on CLABSI rates, 2011. Presented at the SHEA Annual Scientific Meeting, April 1–4, 2011, Dallas, Texas. Abstract #232.Google Scholar
7. Digiorgio, MJ, Fatica, C, Oden, M, et al. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies. Infect Control Hosp Epidemiol 2012;33:865868.CrossRefGoogle ScholarPubMed
8. Worth, LJ, Slavin, MA, Brown, GV, Black, J. Catheter-related bloodstream infections in hematology: time for standardized surveillance? Cancer 2007;109:12151226.CrossRefGoogle Scholar
9. Tancrede, CH, Andremont, AO. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 1985;152:99103.CrossRefGoogle ScholarPubMed
10. Blijlevens, NM, Donnelly, JP, De Pauw, BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000;25:12691278.CrossRefGoogle ScholarPubMed
11. NHSN v7.1 Release Notes. The Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nhsn/pdfs/commup/Release-Notes-v7-1.pdf. Published February 2013. Accessed February 2, 2015.Google Scholar
12. See, I, Iwamoto, M, Allen-Bridson, K, Horan, T, Magill, SS, Thompson, ND. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol 2013;34:769776.CrossRefGoogle ScholarPubMed
13. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central line-associated Bloodstream Infection). The Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf. Published January 2015. Accessed February 3, 2015.Google Scholar
14. National Action Plan to Prevent Health Care-Assocation Infections: Road Map to Elimination. Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, U.S. Department of Health and Human Services Web site. http://www.health.gov/hai/prevent_hai.asp. Accessed March 23, 2015.Google Scholar
15. Gaur, AH, Bundy, DG, Gao, C, et al. Surveillance of hospital-acquired central line-associated bloodstream infections in pediatric hematology-oncology patients: lessons learned, challenges ahead. Infect Control Hosp Epidemiol 2013;34:316320.CrossRefGoogle ScholarPubMed
16. Freeman, JT, Elinder-Camburn, A, McClymont, C, et al. Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity. Infect Control Hosp Epidemiol 2013;34:8992.CrossRefGoogle ScholarPubMed
17. Metzger, KE, Rucker, Y, Callaghan, M, et al. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology and stem cell transplant patients. Infect Control Hosp Epidemiol 2015;36:119124.CrossRefGoogle ScholarPubMed
18. Dudeck, MA, Edwards, JR, Allen-Bridson, K, et al. National Healthcare Safety Network report, data summary for 2013, device-associated module. Am J Infect Control 2015;43:206221.CrossRefGoogle ScholarPubMed

Altmetric attention score

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 37
Total number of PDF views: 256 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 6th March 2021. This data will be updated every 24 hours.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *